Modeling the epidemiologic impact of age-targeted vaccination for drug-resistant tuberculosis
This study used a calibrated mathematical model to evaluate age-specific tuberculosis (TB) vaccination strategies, for drug-resistant (DR)-TB management in China. Prioritizing elderly vaccination significantly reduced multidrug-resistant or rifampicin-resistant TB incidence and mortality, while avoiding the need for second-line treatment, offering a promising approach to mitigate DR-TB burden by 2050.
Authors
- Ting Jiang (ORCID: https://orcid.org/0000-0002-9757-7441)
- Zhixian Chen (ORCID: https://orcid.org/0000-0003-4006-022X)
- Xiao Zang (ORCID: https://orcid.org/0000-0002-5722-8255)
- Yanlin Zhao (ORCID: https://orcid.org/0000-0002-7890-4312)
- Jian Feng
- Pei-Yao Zhai (ORCID: https://orcid.org/0009-0002-7911-618X)
- Bin Zhang (ORCID: https://orcid.org/0000-0003-4407-694X)
- Gang Qin (ORCID: https://orcid.org/0000-0002-4363-2572)
Institutions
- University of Minnesota (US)
- Chinese Center For Disease Control and Prevention (CN)
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
- Twin Cities Orthopedics (US)
- National Center for AIDS/STD Control and Prevention,China CDC (CN)
Publication Details
- Journal
- Drug Resistance Updates
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1016/j.drup.2024.101172
- Citations
- 1
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39